Veracyte (VCYT) Cash & Current Investments (2012 - 2026)

Veracyte (VCYT) has 15 years of Cash & Current Investments data on file, last reported at $263.1 million in Q1 2026.

• Quarterly Cash & Current Investments rose 41.38% year-over-year to $263.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $263.1 million (up 41.38% YoY) and the FY2025 annual result came in at $362.6 million, up 51.65% from the prior year.
• Cash & Current Investments retreated to $263.1 million in Q1 2026 per VCYT's latest filing, from $362.6 million in the prior quarter.
• The five-year high for Cash & Current Investments was $362.6 million in Q4 2025, with the low at $153.4 million in Q2 2022.
• Average Cash & Current Investments over 5 years is $219.7 million, with a median of $209.2 million recorded in 2024.
• Year-over-year, Cash & Current Investments sank 53.15% in 2022 and jumped 51.65% in 2025.
• Veracyte's Cash & Current Investments stood at $154.2 million in 2022, then soared by 40.33% to $216.5 million in 2023, then gained by 10.46% to $239.1 million in 2024, then soared by 51.65% to $362.6 million in 2025, then decreased by 27.43% to $263.1 million in 2026.
• Business Quant data shows VCYT's Cash & Current Investments at $263.1 million in Q1 2026, $362.6 million in Q4 2025, and $315.6 million in Q3 2025.